Literature DB >> 12870724

Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis.

Kai Michael Beeh1, Jutta Beier, Oliver Kornmann, Roland Buhl.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology. Biopsy and bronchoalveolar lavage studies have shown, that accumulation of inflammatory cells, particularily neutrophils, in the alveolar space is a relevant feature of the pathogenesis of IPF. This paper adresses the issue of whether the safe and non-invasive method of sputum induction is a suitable tool to study respiratory tract inflammation in IPF.
METHODS: In a cross-sectional analysis, 15 IPF patients and 14 healthy, non-smoking subjects underwent sputum induction. Total sputum cell counts, differentials, and the amount of interleukin (IL)-8, granulocyte-macrophage-colony stimulating factor (GM-CSF), and soluble ICAM-1 (sICAM) in sputum supernatant were analyzed.
RESULTS: IPF patients had increased sputum neutrophils (60 +/- 6 vs 22 +/- 3%, p = 0.0003), and supernatant concentrations of IL-8 (19 +/- 3 vs. 7 +/- 1 ng/ml, p = 0.0002), GM-CSF (205 +/- 43 vs. 122 +/- 36 pg/ml, p = 0.08) and sICAM (12 +/- 3 vs. 5 +/- 3 ng/ml, p = 0.01), when compared with healthy controls. Sputum IL-8 was correlated with sputum neutrophils (rho = 0.61, p = 0.0006) in all patients. The extent of sputum neutrophilia was also correlated with lung function impairment (vital capacity, % of predicted) in IPF patients (rho = -0.68, p = 0.007).
CONCLUSION: These data confirm the established role of neutrophilic inflammation in the pathogenesis of IPF, and show the potential of induced sputum to directly study inflammatory processes and surrogate markers in interstitial lung diseases like IPF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12870724

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  13 in total

1.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

2.  ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis.

Authors:  Pelagia G Tsoutsou; Konstantinos I Gourgoulianis; Efthymia Petinaki; Maria Mpaka; Smaragda Efremidou; Antonios Maniatis; Pashalis Adam Molyvdas
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

3.  IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3).

Authors:  Karen M Henkels; Kathleen Frondorf; M Elba Gonzalez-Mejia; Andrea L Doseff; Julian Gomez-Cambronero
Journal:  FEBS Lett       Date:  2010-11-21       Impact factor: 4.124

4.  Inhalable powder formulation of pirfenidone with reduced phototoxic risk for treatment of pulmonary fibrosis.

Authors:  Satomi Onoue; Yoshiki Seto; Masashi Kato; Yosuke Aoki; Yoshiki Kojo; Shizuo Yamada
Journal:  Pharm Res       Date:  2013-02-21       Impact factor: 4.200

5.  Airway function and markers of airway inflammation in patients with treated hypothyroidism.

Authors:  S S Birring; R B Patel; D Parker; S McKenna; B Hargadon; W R Monteiro; J F Falconer Smith; I D Pavord
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

6.  Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.

Authors:  Yoshiki Seto; Gen Suzuki; Sharon Shui Yee Leung; Hak-Kim Chan; Satomi Onoue
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200

Review 7.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Benjamin D Bringardner; Christopher P Baran; Timothy D Eubank; Clay B Marsh
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

8.  Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers.

Authors:  P Jacquerie; M Henket; B André; C Moermans; D de Seny; F Gester; R Louis; M Malaise; J Guiot
Journal:  Sci Rep       Date:  2021-05-21       Impact factor: 4.379

9.  Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis.

Authors:  Emmet E McGrath; Allan Lawrie; Helen M Marriott; Paul Mercer; Simon S Cross; Nadine Arnold; Vanessa Singleton; Alfred A R Thompson; Sarah R Walmsley; Stephen A Renshaw; Ian Sabroe; Rachel C Chambers; David H Dockrell; Moira K B Whyte
Journal:  Thorax       Date:  2012-04-11       Impact factor: 9.139

10.  Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7.

Authors:  J Guiot; M Henket; J L Corhay; C Moermans; R Louis
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.